Search results
Results From The WOW.Com Content Network
File:Logo Alcon.svg. File. File history. File usage. Global file usage. Size of this PNG preview of this SVG file: 650 × 169 pixels. Other resolutions: 320 × 83 pixels | 640 × 166 pixels | 1,024 × 266 pixels | 1,280 × 333 pixels | 2,560 × 666 pixels. Original file (SVG file, nominally 650 × 169 pixels, file size: 9 KB) This is a file ...
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
File:Alcon Logo 2019.svg. Size of this PNG preview of this SVG file: 512 × 140 pixels. Other resolutions: 320 × 88 pixels | 640 × 175 pixels | 1,024 × 280 pixels | 1,280 × 350 pixels | 2,560 × 700 pixels. This is a file from the Wikimedia Commons. Information from its description page there is shown below.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
www.allergan.com. Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. [2] It ceased operation in 2015 when it ...
For premium support please call: 800-290-4726 more ways to reach us
Roche. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...